Gene therapy for human nasopharyngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model

Cancer Biotherapy and Radiopharmaceuticals

Volumn 23, Issue 5, 2008, Pages 591-602

  Ren, Su Ping ^a,b   Wang, Lan ^a   Wang, Hua ^a   Wu, Bin ^a   Han, Ying ^b   Wang, Li Sheng ^a   Wu, Chu Tse ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

B7 1 costimulatory molecule; Gene therapy; Granulocyte macrophage colony stimulating factor; Nasopharyngeal carcinoma; p53 tumor suppressor gene

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CANCER GENE THERAPY; CANCER INHIBITION; CANCER MODEL; CANCER PATIENT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; METASTASIS INHIBITION; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; TREATMENT RESPONSE; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; VIRUS RECOMBINANT; WILD TYPE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD80; CARCINOMA; CELL LINE, TUMOR; GENE THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MICE; MICE, SCID; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 55849120499     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.0447     Document Type: Article

References (27)

1. Al-Saraf M, LeBlanc M, Giri PG, et al. Chemotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 1998;16:1310.
2. Chua DT, Sham JS, Au GK, et al. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: Results of a matched cohort analysis. Int I Radiat Oncol Biol Phys 2002;53:334.
3. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005;365:2041.
4. Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma. Lancet 1997;350:1087.
5. Chow E, Payne D, O'Sullivan B, et al. Radiotherapy alone in patients with advanced nasopharyngeal cancer: Comparison with an intergroup study. Is combined modality treatment really necessary? Radiother Oncol 2002;63:269.
6. Sultanem K, Shu HK, Xia P, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California, San Francisco experience. Int J Radiat Oncol Biol Phys 2000;48:711.
7. Resnick-Silverman L, Manfredi JJ. Gene-specific mechanisms of p53 transcriptional control and prospects for cancer therapy. J Cell Biochem 2006;99:679.
8. Edelman J, Edelman J, Nemunaitis J. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region. Curr Opin Mol Ther 2003;5:611.
9. Shimada H, Matsubara H, Shiratori T, et al. Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. Cancer Sci 2006;97:554.
10. Wolf JK, Bodurka DC, Gano JB, et al. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Gynecol Oncol 2004;94:442.
11. Harding FA, McArthur JG, Gross JA, et al. CD28-mediated signalling costimulates murine T-cells and prevents induction of energy in T-cell clones. Nature 1992;356:607.
12. + T-cells by B7-transfected melanoma cells. Science 1993;259:368.
13. Pan PY, Li Y, Li Q, et al. In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery. Cancer Immunol Immunother 2004;53:17.
14. Mellman I, Steinman RM. Dendritic cells: Specialized and regulated antigen processing machines. Cell 2001;106:255.
15. Qiu ZH, Lao MF, Wu ZZ. Construction of recombinant adenovirus coexpressing human wild-type p53, GM-CSF, and B7-1 genes. Chin J Biochem Mol Biol 2001;17:33.
16. Ren SP, Wu CT, Huang WR, et al. Adenoviral-mediated transfer of human wild-type p53, GM-CSF, and B7-1 genes induces growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro. Cancer Immunol Immunother 2006;55:375.
17. Qiu ZH, Wu CT, Lao MF, et al. Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor, and B7-1 genes. Cancer Lett 2002;182:147.
18. Li JH, Lax SA, Kim J, et al. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1999;43:607.
19. Krausa P, Brywka M, Savage D, et al. Genetic polymorphism within HLA-A*02: Significant allelic variation revealed in different populations. Tissue Antigens 1995;45:223.
20. Dotti G, Savoldo B, Takahashi S, et al. Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells. A model for immunotherapy. Exp Hematol 2001;29:952.
21. Chen W, Lee Y, Wang H, et al. Suppression of human nasopharyngeal carcinoma cell growth in nude mice by the wild-type p53 gene. J Cancer Res Clin Oncol 1992;119:46.
22. Weinrib L, Li JH, Donovan J, et al. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and negative nasopharyngeal carcinoma. Cancer Gene Ther 2001;8:352.
23. Qi V, Weinrib L, Ma N, et al. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line. Int J Hyperthermia 2001;17:38.
24. Kosaka K, Yashiro M, Sakate Y, et al. CD80 gene therapy for lymph node involvement by gastric carcinoma. Int J Oncol 2004;25:1319.
25. Collins CG, Tangney M, Larkin JO, et al. Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors. Cancer Gene Ther 2006;13:1061.
26. Lee KH, Piao H, Son BR, et al. Herpes simplex virus thymidine kinase and granulocyte macrophage colony-stimulating factor combination gene therapy in a murine CT26 cell colon cancer model. Cancer Gene Ther 2004;11:570.
27. Liu FF. Novel gene therapy approach for nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:505.